BridgeMD
New treatment option for Endocrine Disruptors in Newborns and Infants
Official title Impact of Parental Training in Endocrine Disruptors on the Excretion of Urinary Biomarkers in Newborns
ClinicalTrials.gov ID: NCT07349927
What this study is testing
What is Urinary dosage?
Urinary dosage is an investigational medicine, given as an once-daily, being studied as a potential treatment for endocrine disruptors in newborns and infants.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The impact of the environment on health, responsible for a quarter of all deaths worldwide and costing more than €160 billion a year, is difficult to assess because of the complexity of exposure and interactions. Endocrine disrupters (EDs), which are omnipresent in our daily lives, affect hormone metabolism and can have long-term consequences, including effects on subsequent generations.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 5. Healthy volunteers may be eligible.
You may be able to join if
- Newborns born at the Bron hospital after 37 weeks of amenorrhea
- Eutrophic
- Affiliated to a social security scheme or beneficiary of a similar scheme
- Consent signed by parents
You likely can't join if
- Congenital anomaly diagnosed antenatally or postnatally
- Parents who do not speak French
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 days to 5 days. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.